期刊文献+

UPLC-MS/MS法测定人血浆中奥氮平、利培酮和帕潘立酮的浓度 被引量:7

Simultaneous Determination of Olanzapine,Risperidone and Paliperidone in Human Plasma by UPLC-MS/MS
暂未订购
导出
摘要 目的:建立同时测定人血浆中奥氮平、利培酮和帕潘立酮浓度的方法。方法:血浆样品经液-液萃取后,以盐酸丁螺环酮为内标,采用超高效液相色谱-串联质谱法测定。色谱柱为ACQUITY UPLCTM BEH C_(18),流动相为甲醇-0.01 mol/L甲酸铵水溶液,梯度洗脱,流速为0.2 mL/min,柱温为45℃,进样量为5μL。采用电喷雾离子源,以多反应监测模式进行正离子扫描,用于定量分析的离子对分别为m/z 313.29→256.25(奥氮平)、m/z 411.42→191.19(利培酮)、m/z 427.45→207.18(帕潘立酮)和m/z 386.43→122.37(内标)。结果:奥氮平、利培酮、帕潘立酮血药浓度分别在0.426~108.954、0.213~54.476、0.213~54.476 ng/mL范围内线性关系良好;日内、日间RSD<20%,方法回收率分别为83.3%~112.9%,90.0%~109.8%和95.2%~114.9%,提取回收率分别为65.5%~95.0%、73.9%~98.5%和73.6%~99.4%,基质效应和稀释效应均不影响待测物血药浓度的测定。采用该法测得100例精神分裂症患者奥氮平、利培酮和帕潘立酮的血药浓度分别为(103.3±73.6)、(13.1±13.1)和(23.2±20.0)ng/mL。结论:该方法简单、快速、灵敏、特异性高,可用于奥氮平、利培酮和帕潘立酮血药浓度测定及药动学研究。 OBJECTIVE: To develop a method for the concentration determination of olanzapine, risperidone and paliperidone in human plasma. METHODS: After liquid-liquid extraction, using buspirone hydrochloride as internal standard, the concentration of plasma sample was determined by UPLC-MS/MS. The determination was performed on ACQUITY UPLCTM BEH C18 column with mobile phase consisted of methanol-0.01 mol/L ammonium formate solution (gradient elution) at flow rate of 0.2 mL/min. The column temperature was 45 ℃, and sample size was 5 μL. The electrospray ionization source was adopted for positive ion scanning under MRM mode. Ion-pairs for quantitative analysis were as follows: m/z 313.29→256.25 (olanzapine), m/z 411.42→191.19 (risperidone), m/z 427.45→207.18 (paliperidone) and m/z 386.43→122.37 (internal standard). RESULTS: The linear ranges of olanzapine, risperidone and paliperidone were 0.426-108.954, 0.213-54.476, 0.213-54.476 ng/mL, respectively. RSDs of inter-day and intra-day were all lower than 20%. The recoveries of them ranged 83.3%-112.9%, 90.0%-109.8% and 95.2%-114.9%, respectively. Extraction recoveries ranged 65.5%-95.0%, 73.9%-98.5% and 73.6%-99.4%, respectively. Both plasma matrix effect and dilute effect didn't influence the determination of plasma concentration. The plasma concentrations of olanzapine, risperidone and paliperidone in 100 schizophrenia patients were (103.3 ± 73.6), (13.1 ± 13.1) and (23.2 ± 20.0) ng/mL, respectively. CONCLUSIONS: The method is simple, rapid, sensitive and specific. It can be used for the determination of plasma concentration and pharmacodynamic study of olanzapine, risperidone and paliperidone.
出处 《中国药房》 CAS 北大核心 2017年第8期1045-1048,共4页 China Pharmacy
关键词 奥氮平 利培酮 帕潘立酮 超高效液相色谱-串联质谱法 血药浓度 Olanzapine Risperidone Paliperidone UPLC-MS/MS Plasma concentration
  • 相关文献

参考文献13

二级参考文献150

  • 1孟珺,何光明,刘丽娟.反相高效液相色谱法测定利培酮及其活性代谢物的血药浓度[J].深圳中西医结合杂志,2005,15(3):178-179. 被引量:3
  • 2王筱兰,侯钢.双相情感障碍混合状态的研究进展[J].国际精神病学杂志,2006,33(3):167-170. 被引量:7
  • 3HORI H, YOSHIMURA R, YAMADA Y, et al. Effects of olanzapine on plasma levels of catecholamine metabolites,cytokines, and brain-derived neurotrophic factor in schizophrenic patients[J]. Int ClinPsyehopharmacol, 2007, 22(1):21-27.
  • 4RAGGI M A, CASAMENTI G, MANDRIOLI R, et al. Quantitation of olanzapine in tablets by HPLC CZE,derivative spectrometry and linearvoltammetry[J].JPharmBiomedAnal, 2000, 23(6):973-981.
  • 5BERNA M, SHUGERT R, MULLEN J. Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry[J]. JMass Spectrom, 1998, 33(10):1003-1008.
  • 6BERNA M, ACKERMANN B, RUTERBORIES K, et aL Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2002, 767(1): 163-168.
  • 7Chwieduk CM, Keating GM. Paliperidone extended release: a review of its use in the management of schizophrenia [ J ]. Drug, 2010,70 : 1295-1317.
  • 8Leon JD, Wynn G, Sandson NB. The pharmacokinetics of paliperidone versus risperidone[ J]. Psychosomatics ,2010,51:80-88.
  • 9喻东山.精神疾病临床治疗手[M].南京:江苏科学技术出版社,2009:11.
  • 10Si T, Shu L, Si Y, et al. Single-dose pharmacokinetics of paliperidone extended-release tablets in healthy Chinese subjects [ J ]. Hum Psychopharmacol Clin Exp,2010,25:404-409.

共引文献70

同被引文献68

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部